JP2014532413A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014532413A5 JP2014532413A5 JP2014539033A JP2014539033A JP2014532413A5 JP 2014532413 A5 JP2014532413 A5 JP 2014532413A5 JP 2014539033 A JP2014539033 A JP 2014539033A JP 2014539033 A JP2014539033 A JP 2014539033A JP 2014532413 A5 JP2014532413 A5 JP 2014532413A5
- Authority
- JP
- Japan
- Prior art keywords
- human
- segment
- animal
- endogenous
- segments
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161552582P | 2011-10-28 | 2011-10-28 | |
| US61/552,582 | 2011-10-28 | ||
| US201261621198P | 2012-04-06 | 2012-04-06 | |
| US61/621,198 | 2012-04-06 | ||
| US201261700908P | 2012-09-14 | 2012-09-14 | |
| US61/700,908 | 2012-09-14 | ||
| PCT/US2012/062065 WO2013063361A1 (en) | 2011-10-28 | 2012-10-26 | Genetically modified t cell receptor mice |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017205098A Division JP6532924B2 (ja) | 2011-10-28 | 2017-10-24 | 遺伝子改変ｔ細胞受容体マウス |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014532413A JP2014532413A (ja) | 2014-12-08 |
| JP2014532413A5 true JP2014532413A5 (https=) | 2015-12-17 |
| JP6254528B2 JP6254528B2 (ja) | 2017-12-27 |
Family
ID=47178340
Family Applications (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014539033A Active JP6254528B2 (ja) | 2011-10-28 | 2012-10-26 | 遺伝子改変ｔ細胞受容体マウス |
| JP2017205098A Active JP6532924B2 (ja) | 2011-10-28 | 2017-10-24 | 遺伝子改変ｔ細胞受容体マウス |
| JP2018231026A Active JP6706311B2 (ja) | 2011-10-28 | 2018-12-10 | 遺伝子改変ｔ細胞受容体マウス |
| JP2020085787A Withdrawn JP2020146045A (ja) | 2011-10-28 | 2020-05-15 | 遺伝子改変ｔ細胞受容体マウス |
| JP2022075908A Active JP7305840B2 (ja) | 2011-10-28 | 2022-05-02 | 遺伝子改変ｔ細胞受容体マウス |
| JP2022208112A Active JP7656580B2 (ja) | 2011-10-28 | 2022-12-26 | 遺伝子改変ｔ細胞受容体マウス |
| JP2023214715A Withdrawn JP2024019646A (ja) | 2011-10-28 | 2023-12-20 | 遺伝子改変ｔ細胞受容体マウス |
Family Applications After (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017205098A Active JP6532924B2 (ja) | 2011-10-28 | 2017-10-24 | 遺伝子改変ｔ細胞受容体マウス |
| JP2018231026A Active JP6706311B2 (ja) | 2011-10-28 | 2018-12-10 | 遺伝子改変ｔ細胞受容体マウス |
| JP2020085787A Withdrawn JP2020146045A (ja) | 2011-10-28 | 2020-05-15 | 遺伝子改変ｔ細胞受容体マウス |
| JP2022075908A Active JP7305840B2 (ja) | 2011-10-28 | 2022-05-02 | 遺伝子改変ｔ細胞受容体マウス |
| JP2022208112A Active JP7656580B2 (ja) | 2011-10-28 | 2022-12-26 | 遺伝子改変ｔ細胞受容体マウス |
| JP2023214715A Withdrawn JP2024019646A (ja) | 2011-10-28 | 2023-12-20 | 遺伝子改変ｔ細胞受容体マウス |
Country Status (25)
| Country | Link |
|---|---|
| US (4) | US9113616B2 (https=) |
| EP (3) | EP3795587A1 (https=) |
| JP (7) | JP6254528B2 (https=) |
| KR (5) | KR102542272B1 (https=) |
| CN (5) | CN107858333B (https=) |
| AU (5) | AU2012327204B2 (https=) |
| BR (1) | BR112014009203B1 (https=) |
| CA (1) | CA2853707A1 (https=) |
| CY (2) | CY1120945T1 (https=) |
| DK (2) | DK3424947T3 (https=) |
| ES (2) | ES2691475T3 (https=) |
| HR (2) | HRP20181626T1 (https=) |
| HU (1) | HUE053444T2 (https=) |
| IL (4) | IL315445A (https=) |
| IN (1) | IN2014CN03890A (https=) |
| LT (2) | LT3424947T (https=) |
| MX (2) | MX353134B (https=) |
| PL (2) | PL2771357T3 (https=) |
| PT (2) | PT3424947T (https=) |
| RS (2) | RS61455B1 (https=) |
| RU (1) | RU2661106C2 (https=) |
| SG (2) | SG11201401030WA (https=) |
| SI (2) | SI3424947T1 (https=) |
| SM (2) | SMT202100243T1 (https=) |
| WO (1) | WO2013063361A1 (https=) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107858333B (zh) * | 2011-10-28 | 2022-05-27 | 瑞泽恩制药公司 | T细胞受体基因修饰小鼠 |
| US20150073043A1 (en) * | 2012-01-19 | 2015-03-12 | Institut Pasteur Of Shanghai, Chinese Academy Of Sciences | Use of phosphorylation pathway-related factor in regulating function of regulatory t cell |
| SG11201406547YA (en) | 2012-04-25 | 2014-11-27 | Regeneron Pharma | Nuclease-mediated targeting with large targeting vectors |
| GB2508414A (en) * | 2012-11-30 | 2014-06-04 | Max Delbrueck Centrum | Tumour specific T cell receptors (TCRs) |
| US20150342163A1 (en) | 2013-02-22 | 2015-12-03 | Regeneron Pharmaceuticals, Inc. | Genetically modified major histocompatibility complex mice |
| DK3456831T3 (da) | 2013-04-16 | 2021-09-06 | Regeneron Pharma | Målrettet modifikation af rottegenom |
| KR102170502B1 (ko) | 2013-12-11 | 2020-10-28 | 리제너론 파마슈티칼스 인코포레이티드 | 게놈의 표적화된 변형을 위한 방법 및 조성물 |
| TWI681969B (zh) * | 2014-01-23 | 2020-01-11 | 美商再生元醫藥公司 | 針對ｐｄ-１的人類抗體 |
| HRP20200529T1 (hr) | 2014-06-06 | 2020-09-04 | Regeneron Pharmaceuticals, Inc. | Postupci i pripravci za modificiranje ciljnog lokusa |
| IL287519B2 (en) * | 2014-06-19 | 2024-01-01 | Regeneron Pharma | Non-human animals having a humanized programmed cell death 1 gene |
| SI3161128T1 (sl) | 2014-06-26 | 2019-02-28 | Regeneron Pharmaceuticals, Inc. | Postopki in sestavki za ciljano genetsko spremembo in postopki uporabe |
| JP2017529841A (ja) | 2014-09-19 | 2017-10-12 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | キメラ抗原受容体 |
| KR102531016B1 (ko) | 2014-11-21 | 2023-05-10 | 리제너론 파마슈티칼스 인코포레이티드 | 쌍 형성된 가이드 rna를 사용하는 표적화된 유전자 변형을 위한 방법 및 조성물 |
| RU2726446C2 (ru) * | 2014-11-24 | 2020-07-14 | Регенерон Фармасьютикалз, Инк. | Не относящиеся к человеку животные, экспрессирующие гуманизированный комплекс cd3 |
| ES2947714T3 (es) | 2014-12-19 | 2023-08-17 | Regeneron Pharma | Métodos y composiciones para la modificación genética dirigida a través de múltiples direccionamientos en un solo paso |
| EP4248744A3 (en) * | 2015-04-06 | 2023-12-27 | Regeneron Pharmaceuticals, Inc. | Humanized t cell mediated immune responses in non-human animals |
| EP3711488A1 (en) | 2015-05-06 | 2020-09-23 | Snipr Technologies Limited | Altering microbial populations & modifying microbiota |
| WO2017087780A1 (en) | 2015-11-20 | 2017-05-26 | Regeneron Pharmaceuticals, Inc. | Non-human animals having a humanized lymphocyte-activation gene 3 |
| US20190161530A1 (en) * | 2016-04-07 | 2019-05-30 | Bluebird Bio, Inc. | Chimeric antigen receptor t cell compositions |
| SMT202200306T1 (it) | 2016-04-08 | 2022-09-14 | Immunocore Ltd | Recettori di cellule t |
| KR102483193B1 (ko) | 2016-06-03 | 2023-01-04 | 리제너론 파마슈티칼스 인코포레이티드 | 외인성 말단 데옥시뉴클레오타이드 전달효소를 발현하는 비인간 동물 |
| GB201609811D0 (en) | 2016-06-05 | 2016-07-20 | Snipr Technologies Ltd | Methods, cells, systems, arrays, RNA and kits |
| EP3638262A4 (en) | 2017-06-16 | 2021-03-24 | Mayo Foundation for Medical Education and Research | MATERIALS AND METHODS FOR INCREASING IMMUNE REACTION |
| JP2020537515A (ja) | 2017-10-03 | 2020-12-24 | ジュノー セラピューティクス インコーポレイテッド | Ｈｐｖ特異的結合分子 |
| US10760075B2 (en) | 2018-04-30 | 2020-09-01 | Snipr Biome Aps | Treating and preventing microbial infections |
| CA3094468A1 (en) * | 2018-04-05 | 2019-10-10 | Juno Therapeutics, Inc. | Methods of producing cells expressing a recombinant receptor and related compositions |
| SG11202101789SA (en) * | 2018-07-26 | 2021-03-30 | Univ Kyoto | Method for generating cells into which an exogenous antigen receptor is introduced |
| US11851663B2 (en) | 2018-10-14 | 2023-12-26 | Snipr Biome Aps | Single-vector type I vectors |
| MX2022002984A (es) * | 2019-09-12 | 2022-06-16 | Tcr2 Therapeutics Inc | Composiciones y métodos para la reprogramación de tcr mediante el uso de proteínas de fusión. |
| US20220409732A1 (en) | 2019-12-02 | 2022-12-29 | Regeneron Pharmaceuticals, Inc. | Peptide-mhc ii protein constructs and uses thereof |
| CA3177181A1 (en) * | 2020-03-27 | 2021-09-30 | 2Seventy Bio, Inc. | T cell receptors |
| CN113684258B (zh) * | 2020-05-18 | 2024-08-20 | 上海赛比曼生物科技有限公司 | 用于检测鼠源tcr转基因拷贝数的试剂盒及方法 |
| CN118511853A (zh) | 2021-03-31 | 2024-08-20 | 瑞泽恩制药公司 | 包含具有改善的tcrb组库多样性的人源化细胞免疫系统组分的基因修饰的小鼠 |
| GB202209518D0 (en) | 2022-06-29 | 2022-08-10 | Snipr Biome Aps | Treating & preventing E coli infections |
| WO2024035962A2 (en) * | 2022-08-12 | 2024-02-15 | Ingenious Targeting Laboratories | Genetically modified non-human having humanized gamma and delta tcr variable genes |
| KR20250070621A (ko) | 2022-08-18 | 2025-05-20 | 이뮤노코어 리미티드 | Mage-a4에 특이적인 t 세포 수용체 융합 단백질 |
| AU2023347224A1 (en) * | 2022-09-22 | 2025-03-20 | Regeneron Pharmaceuticals, Inc. | Genetically modified mice expressing components of human cellular immune system |
| TW202520975A (zh) | 2023-08-09 | 2025-06-01 | 英商劍橋企業有限公司 | 基因改造之囓齒動物及囓齒動物細胞以及其等用途 |
| GB2642411A (en) | 2024-04-22 | 2026-01-14 | T Therapeutics Ltd | T Cell Receptor identification and provision |
| GB2640828A (en) | 2024-04-22 | 2025-11-12 | T Therapeutics Ltd | Methods and products for the generation and identification of T cells and TCRs |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
| US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| EP0663952A4 (en) | 1992-09-11 | 1997-06-11 | Univ California | Transgenic non-human animals having targeted lymphocyte transduction genes. |
| US5523226A (en) | 1993-05-14 | 1996-06-04 | Biotechnology Research And Development Corp. | Transgenic swine compositions and methods |
| CA2246333A1 (en) | 1996-03-05 | 1997-09-12 | The Scripps Research Institute | Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens |
| US6320306B1 (en) * | 1996-08-05 | 2001-11-20 | Samsung Display Devices Co., Ltd. | Shadow mask with porous insulating layer and heavy metal layer |
| CA2722378C (en) | 1996-12-03 | 2015-02-03 | Amgen Fremont Inc. | Human antibodies that bind tnf.alpha. |
| AU1023401A (en) | 1999-10-12 | 2001-04-23 | Institut Pasteur | Design of a polyepitopic construct for the induction of hla-a2.1 restricted hiv 1 specific ctl responses using hhd mice |
| US7462486B2 (en) | 2000-05-12 | 2008-12-09 | Oregon Health & Science University | Methods of selecting T cell receptor V peptides for therapeutic use |
| US6596541B2 (en) * | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US7105348B2 (en) | 2000-10-31 | 2006-09-12 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US6586251B2 (en) | 2000-10-31 | 2003-07-01 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| WO2002047474A1 (en) * | 2000-12-13 | 2002-06-20 | Sumitomo Pharmaceuticals Company, Limited | Transgenic animal expressing hla-a24 and utilization thereof |
| ES2389251T3 (es) | 2000-12-19 | 2012-10-24 | Altor Bioscience Corporation | Animales transgénicos que comprenden un sistema inmunitario humanizado |
| FR2827302B1 (fr) | 2001-07-13 | 2003-10-10 | Genoway | Cellule et animal transgenique modelisant la presentation antigenique humaine et leurs utilisations |
| IL160359A0 (en) | 2001-08-31 | 2004-07-25 | Avidex Ltd | Soluble t cell receptor |
| EP1452093A4 (en) | 2001-11-15 | 2007-08-15 | Kirin Brewery | CHIMESE NON-MENTAL ANIMAL |
| DK1321477T3 (da) * | 2001-12-22 | 2005-02-14 | 4Antibody Ag | Fremgangsmåde til frembringelsen af genetisk modificerede vertebrate precursor-lymfocytter og anvendelse deraf til fremstillingen af heterologe bindende proteiner |
| JP4238138B2 (ja) | 2001-12-22 | 2009-03-11 | ４−アンチボディ アーゲー | 遺伝的に修飾された脊椎動物前駆体リンパ球の生成方法及び異種結合タンパク質の産生を目的としたその使用。 |
| DE10244457A1 (de) | 2002-09-24 | 2004-04-01 | Johannes-Gutenberg-Universität Mainz | Verfahren zur rationalen Mutagenese von alpha/beta T-Zell Rezeptoren und entsprechend mutierte MDM2-Protein spezifische alpha/beta T-Zell Rezeptoren |
| CA2501870C (en) | 2002-10-09 | 2013-07-02 | Avidex Limited | Single chain recombinant t cell receptors |
| US20060156419A1 (en) * | 2002-10-30 | 2006-07-13 | The Wistar Institute Of Anatomy And Biology | Mouse model for autoimmune disorders |
| US7663017B2 (en) * | 2003-07-30 | 2010-02-16 | Institut Pasteur | Transgenic mice having a human major histocompatability complex (MHC) phenotype, experimental uses and applications |
| ES2463476T3 (es) | 2004-10-19 | 2014-05-28 | Regeneron Pharmaceuticals, Inc. | Método para generar un ratón homocigótico para una modificación genética |
| CA2651174A1 (en) * | 2006-05-03 | 2007-11-15 | Government Of The United States Of America, Represented By The Secretary , Department Of Health And Human Services | Chimeric t cell receptors and related materials and methods of use |
| EP1878342A1 (en) | 2006-07-13 | 2008-01-16 | Institut Pasteur | Immunodeficient mice transgenic for HLA class I and HLA class II molecules and their uses |
| US9388425B2 (en) | 2006-10-20 | 2016-07-12 | Trustees Of Boston University | Tunable genetic switch for regulating gene expression |
| JP2008159109A (ja) | 2006-12-21 | 2008-07-10 | Matsushita Electric Ind Co Ltd | データ転送装置 |
| TWI476280B (zh) | 2008-03-07 | 2015-03-11 | Regeneron Pharma | 來自二倍體宿主胚胎注射之ｅｓ－細胞衍生的老鼠 |
| US20090328240A1 (en) | 2008-06-24 | 2009-12-31 | Sing George L | Genetically modified mice as predictors of immune response |
| WO2010107400A1 (en) | 2009-03-20 | 2010-09-23 | Agency For Science, Technology And Research | Genetically modified animal and method of obtaining the same |
| DK3622815T3 (da) * | 2009-07-08 | 2023-06-26 | Kymab Ltd | Gnavermodeller og terapeutiske molekyler |
| RU2425880C2 (ru) | 2009-07-30 | 2011-08-10 | Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН | Способ получения трансгенных мышей |
| GB0917090D0 (en) | 2009-09-29 | 2009-11-11 | Ucl Biomedica Plc | T-cell receptor |
| EP2486049A1 (en) | 2009-10-06 | 2012-08-15 | The Board Of Trustees Of The UniversityOf Illinois | Human single-chain t cell receptors |
| US8956828B2 (en) | 2009-11-10 | 2015-02-17 | Sangamo Biosciences, Inc. | Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases |
| ES2984483T3 (es) | 2010-03-31 | 2024-10-29 | Ablexis Llc | Ingeniería genética de ratones para la producción de anticuerpos quiméricos |
| CN103025884B (zh) | 2010-07-26 | 2015-11-25 | 特里安尼公司 | 转基因动物和使用方法 |
| US9557323B2 (en) | 2010-09-24 | 2017-01-31 | The United States Of America As Represented By The Secretary Of The Navy | Humanized transgenic mouse model |
| CN103348012B (zh) | 2010-11-27 | 2016-06-08 | 朱坚 | 一种人源化的转基因动物 |
| CN107858333B (zh) * | 2011-10-28 | 2022-05-27 | 瑞泽恩制药公司 | T细胞受体基因修饰小鼠 |
| EP4248744A3 (en) | 2015-04-06 | 2023-12-27 | Regeneron Pharmaceuticals, Inc. | Humanized t cell mediated immune responses in non-human animals |
| IL318469A (en) | 2018-06-14 | 2025-03-01 | Regeneron Pharma | Non-human animals capable of reorganizing transgenic DH-DH, and their uses |
-
2012
- 2012-10-26 CN CN201710930556.4A patent/CN107858333B/zh active Active
- 2012-10-26 JP JP2014539033A patent/JP6254528B2/ja active Active
- 2012-10-26 CN CN201280064216.3A patent/CN104011071B/zh active Active
- 2012-10-26 WO PCT/US2012/062065 patent/WO2013063361A1/en not_active Ceased
- 2012-10-26 ES ES12784833T patent/ES2691475T3/es active Active
- 2012-10-26 IL IL315445A patent/IL315445A/en unknown
- 2012-10-26 IL IL274914A patent/IL274914B2/en unknown
- 2012-10-26 ES ES18176096T patent/ES2858978T3/es active Active
- 2012-10-26 AU AU2012327204A patent/AU2012327204B2/en active Active
- 2012-10-26 HR HRP20181626TT patent/HRP20181626T1/hr unknown
- 2012-10-26 MX MX2014004894A patent/MX353134B/es active IP Right Grant
- 2012-10-26 SM SM20210243T patent/SMT202100243T1/it unknown
- 2012-10-26 BR BR112014009203-6A patent/BR112014009203B1/pt active IP Right Grant
- 2012-10-26 SM SM20180553T patent/SMT201800553T1/it unknown
- 2012-10-26 RS RS20210210A patent/RS61455B1/sr unknown
- 2012-10-26 SG SG11201401030WA patent/SG11201401030WA/en unknown
- 2012-10-26 KR KR1020227015694A patent/KR102542272B1/ko active Active
- 2012-10-26 KR KR1020197008815A patent/KR102148387B1/ko active Active
- 2012-10-26 SI SI201231885T patent/SI3424947T1/sl unknown
- 2012-10-26 EP EP20198394.7A patent/EP3795587A1/en active Pending
- 2012-10-26 PL PL12784833T patent/PL2771357T3/pl unknown
- 2012-10-26 RS RS20181207A patent/RS57893B1/sr unknown
- 2012-10-26 KR KR1020147014477A patent/KR101964776B1/ko active Active
- 2012-10-26 US US13/661,342 patent/US9113616B2/en active Active
- 2012-10-26 PT PT181760968T patent/PT3424947T/pt unknown
- 2012-10-26 SG SG10201914043XA patent/SG10201914043XA/en unknown
- 2012-10-26 CN CN202210507359.2A patent/CN114891797A/zh active Pending
- 2012-10-26 CN CN201710930555.XA patent/CN107858332A/zh active Pending
- 2012-10-26 SI SI201231413T patent/SI2771357T1/sl unknown
- 2012-10-26 LT LTEP18176096.8T patent/LT3424947T/lt unknown
- 2012-10-26 PT PT12784833T patent/PT2771357T/pt unknown
- 2012-10-26 DK DK18176096.8T patent/DK3424947T3/da active
- 2012-10-26 CN CN202210507387.4A patent/CN114891798B/zh active Active
- 2012-10-26 DK DK12784833.1T patent/DK2771357T3/en active
- 2012-10-26 KR KR1020207024033A patent/KR102321909B1/ko active Active
- 2012-10-26 MX MX2017012602A patent/MX379517B/es unknown
- 2012-10-26 LT LTEP12784833.1T patent/LT2771357T/lt unknown
- 2012-10-26 CA CA2853707A patent/CA2853707A1/en active Pending
- 2012-10-26 IN IN3890CHN2014 patent/IN2014CN03890A/en unknown
- 2012-10-26 EP EP12784833.1A patent/EP2771357B1/en active Active
- 2012-10-26 PL PL18176096T patent/PL3424947T3/pl unknown
- 2012-10-26 IL IL305550A patent/IL305550B2/en unknown
- 2012-10-26 RU RU2014121160A patent/RU2661106C2/ru active
- 2012-10-26 KR KR1020217035333A patent/KR102397961B1/ko active Active
- 2012-10-26 HU HUE18176096A patent/HUE053444T2/hu unknown
- 2012-10-26 EP EP18176096.8A patent/EP3424947B1/en active Active
-
2014
- 2014-04-13 IL IL232098A patent/IL232098B/en active IP Right Grant
-
2015
- 2015-07-14 US US14/799,355 patent/US11528895B2/en active Active
-
2016
- 2016-04-20 AU AU2016202512A patent/AU2016202512C1/en active Active
-
2017
- 2017-10-24 JP JP2017205098A patent/JP6532924B2/ja active Active
-
2018
- 2018-06-28 AU AU2018204700A patent/AU2018204700C1/en active Active
- 2018-10-16 CY CY181101057T patent/CY1120945T1/el unknown
- 2018-12-10 JP JP2018231026A patent/JP6706311B2/ja active Active
-
2020
- 2020-05-15 JP JP2020085787A patent/JP2020146045A/ja not_active Withdrawn
- 2020-10-27 US US17/081,470 patent/US12582105B2/en active Active
-
2021
- 2021-02-15 HR HRP20210256TT patent/HRP20210256T1/hr unknown
- 2021-02-19 CY CY20211100142T patent/CY1123831T1/el unknown
- 2021-05-18 AU AU2021203192A patent/AU2021203192B2/en active Active
-
2022
- 2022-05-02 JP JP2022075908A patent/JP7305840B2/ja active Active
- 2022-07-22 US US17/814,388 patent/US20220386575A1/en not_active Abandoned
- 2022-12-26 JP JP2022208112A patent/JP7656580B2/ja active Active
-
2023
- 2023-12-20 JP JP2023214715A patent/JP2024019646A/ja not_active Withdrawn
-
2024
- 2024-07-04 AU AU2024204645A patent/AU2024204645A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014532413A5 (https=) | ||
| JP7386292B2 (ja) | 操作されたイムノグロブリンラムダ軽鎖座位を有する非ヒト動物 | |
| RU2014121160A (ru) | Генетически модифицированные в отношении т-клеточного рецептора мыши | |
| US12356967B2 (en) | Immunoglobulin lambda light chain and uses thereof | |
| EP3609319B1 (en) | Mouse models and therapeutic molecules | |
| EP3622813B2 (en) | Animal models and therapeutic molecules | |
| JP2017513520A5 (https=) | ||
| CN108467873B (zh) | 一种cd132基因缺失的免疫缺陷动物模型的制备方法及应用 | |
| EP2582230A1 (en) | Animal models and therapeutic molecules | |
| CN109136275A (zh) | 人源化gitr基因改造动物模型的制备方法及应用 | |
| TW202520975A (zh) | 基因改造之囓齒動物及囓齒動物細胞以及其等用途 | |
| Eguren-Santamaria et al. | Preclinical ex vivo and in vivo models to study immunotherapy agents and their combinations as predictive tools toward the clinic | |
| JP2025537422A (ja) | 共通軽鎖を発現するげっ歯類 | |
| HK40058708B (en) | Rodent models and therapeutic molecules | |
| Wang | Molecular analysis of the interaction between T cell receptors and the VSV peptide presented by murine class I H-2K (b) molecules in TCR (alpha) chain transgenic mice | |
| HK40075382B (en) | Rodent models and therapeutic antibodies | |
| HK1180535B (en) | Animal models and therapeutic molecules |